CAPN3

Limb-girdle muscular dystrophy

More than 300 mutations in the CAPN3 gene have been identified in people with limb-girdle muscular dystrophy type 2A. This form of limb-girdle muscular dystrophy is also called calpainopathy.

Limb-girdle muscular dystrophy is a group of related disorders characterized by muscle weakness and wasting, particularly in the shoulders, hips, and limbs. CAPN3 gene mutations are the most common cause of limb-girdle muscular dystrophy. These mutations account for approximately 30 percent of limb-girdle muscular dystrophy cases overall, although the percentage varies by specific population.

Most CAPN3 gene mutations change one protein building block (amino acid) in the calpain-3 enzyme. These mutations result in a calpain-3 enzyme that is abnormally short or unstable. Disruption of the enzyme's ability to properly cleave proteins for removal from the sarcomere may allow these waste proteins to accumulate in muscle tissue and become toxic. Other mechanisms have also been suggested to account for the muscle damage that underlies limb-girdle muscular dystrophy in people with CAPN3 gene mutations.